Fresenius Kabi's Biosimilar Adalimumab, Idacio, Is Similar to Humira in RA in Terms of Safety Medical Health News, 14 Aug 2019 Fresenius Kabi’s biosimilar adalimumab, Idacio, recently launched in the German market.